Open AccessEfficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1
Author(s) -
Okayama Yusuke,
Takakuwa Teruhito,
Otomaru Ippei,
Horiuchi Mirei,
Miura Akiko,
Araki Taku,
Fujitani Yotaro,
Yamamura Ryosuke
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4126
Subject(s) - medicine , imatinib , phenotype , philadelphia chromosome , oncology , leukemia , imatinib mesylate , chromosomal translocation , gene , myeloid leukemia , genetics , biology
Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom